Dimensional Fund Advisors
GBT

Dimensional Fund Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Dimensional Fund Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6.01M Sell
88,277
-1,137
-1% -$62.7K ﹤0.01% 2360
2022
Q2 		$2.86M Sell
89,414
-441,279
-83% -$12.9M ﹤0.01% 2633
2022
Q1 		$18.4M Buy
530,693
+111,130
+26% +$3.32M 0.01% 2005
2021
Q4 		$12.3M Buy
419,563
+81,056
+24% +$2.51M ﹤0.01% 2223
2021
Q3 		$8.63M Sell
338,507
-62,145
-16% -$1.83M ﹤0.01% 2393
2021
Q2 		$14M Buy
400,652
+23,146
+6% +$904K ﹤0.01% 2206
2021
Q1 		$15.4M Sell
377,506
-32,612
-8% -$1.5M 0.01% 2133
2020
Q4 		$17.8M Sell
410,118
-45,319
-10% -$2.23M 0.01% 2039
2020
Q3 		$25.1M Sell
455,437
-9,491
-2% -$603K 0.01% 1731
2020
Q2 		$29.4M Sell
464,928
-17,935
-4% -$1.23M 0.01% 1619
2020
Q1 		$24.7M Sell
482,863
-7,629
-2% -$511K 0.01% 1601
2019
Q4 		$39M Buy
490,492
+41,076
+9% +$2.43M 0.01% 1648
2019
Q3 		$21.8M Buy
449,416
+8,333
+2% +$434K 0.01% 1956
2019
Q2 		$23.2M Sell
441,083
-40,786
-8% -$2.34M 0.01% 1967
2019
Q1 		$25.5M Sell
481,869
-10,551
-2% -$518K 0.01% 1921
2018
Q4 		$20.2M Buy
492,420
+409,934
+497% +$15.4M 0.01% 1965
2018
Q3 		$3.13M Buy
+82,486
New +$3.65M ﹤0.01% 2810

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors's GBT Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its Global Blood Therapeutics, Inc. (GBT) stake by 1.3% in Q3 2022, selling an estimated $62.7K and leaving 88,277 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Dimensional Fund Advisors first reported a position in GBT in Q3 2018 and has held it in 17 quarters since. The position peaked at $39M in Q4 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Dimensional Fund Advisors held 88,277 shares of Global Blood Therapeutics, Inc. worth $6.01M as of Q3 2022.
  • Dimensional Fund Advisors sold 1,137 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $62.7K.
  • Global Blood Therapeutics, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2360 holding.
  • Dimensional Fund Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2018 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Global Blood Therapeutics, Inc. position peaked at $39M in Q4 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.